Cargando…

Automated lung sound analysis using the LungPass platform: a sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19

Automated lung sound analysis using the #LungPass platform is a sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19 https://bit.ly/3tyAgOD

Detalles Bibliográficos
Autores principales:	Lapteva, Elena A., Kharevich, Olga N., Khatsko, Victoria V., Voronova, Natalia A., Chamko, Maksim V., Bezruchko, Irina V., Katibnikova, Elena I., Loban, Elena I., Mouawie, Mostafa M., Binetskaya, Helena, Aleshkevich, Sergey, Karankevich, Aleksey, Dubinetski, Vitaly, Vestbo, Jørgen, Mathioudakis, Alexander G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754101/ https://www.ncbi.nlm.nih.gov/pubmed/34531278 http://dx.doi.org/10.1183/13993003.01907-2021

Ejemplares similares

COVID-19 in Italy: passing through bitter waters
por: Guglielmetti, Lorenzo, et al.
Publicado: (2020)

Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population
por: Taylor-Robinson, David C., et al.
Publicado: (2014)

MEK5 promotes lung adenocarcinoma
por: Sánchez-Fdez, Adrián, et al.
Publicado: (2019)

COVID-19: opacification score is higher in the right lung and right lung involvement is a better predictor of ICU admission
por: Nagra, Deepak, et al.
Publicado: (2020)

The burden of progressive fibrotic interstitial lung disease across the UK
por: Simpson, Thomas, et al.
Publicado: (2021)

Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
por: Brown, Kevin K., et al.
Publicado: (2020)

Bile acid aspiration in people with cystic fibrosis before and after lung transplantation
por: Brodlie, Malcolm, et al.
Publicado: (2015)

Implementation of digital technology solutions for a lung health trial in rural Malawi
por: Chisunkha, Blessings, et al.
Publicado: (2016)

Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence
por: Schaeffer, Michele R., et al.
Publicado: (2017)

Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence
por: Bell, Emily C., et al.
Publicado: (2017)

Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure
por: Michalick, Laura, et al.
Publicado: (2021)

Increased focus on non-animal models for COVID-19 and non-COVID lung research
por: Gribaldo, Laura, et al.
Publicado: (2021)

Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD
por: Vestbo, Jørgen, et al.
Publicado: (2022)

An observational study of the lung clearance index throughout childhood in cystic fibrosis: early years matter
por: Davies, Gwyneth, et al.
Publicado: (2020)

Lung function during and after acute respiratory infection in COVID-19 positive and negative outpatients
por: Tamminen, Pekka, et al.
Publicado: (2022)

Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection
por: Trinkmann, Frederik, et al.
Publicado: (2021)

The potential and challenges of radiomics in uncovering prognostic and molecular differences in interstitial lung disease associated with systemic sclerosis
por: Zhang, Lu, et al.
Publicado: (2022)

Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors
por: Rinaldo, Rocco Francesco, et al.
Publicado: (2021)

High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
por: Dhooria, Sahajal, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2021)

Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV
por: Kerkhoff, Andrew D., et al.
Publicado: (2020)

Smoke-free vehicles: impact of legislation on child smoke exposure across three countries
por: Laverty, Anthony A., et al.
Publicado: (2021)

Does a single Pseudomonas aeruginosa isolation predict COPD mortality?
por: Boutou, Afroditi K., et al.
Publicado: (2014)

Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort
por: Holz, Olaf, et al.
Publicado: (2021)

Noninterventional statistical comparison of BTS and CHEST guidelines for size and severity in primary pneumothorax
por: Nikolić, Marko Z., et al.
Publicado: (2015)

Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support
por: Riera, Jordi, et al.
Publicado: (2022)

Reply to: Cause or consequence?
por: Bateman, Eric D., et al.
Publicado: (2022)

Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box project
por: Dirikgil, Ebru, et al.
Publicado: (2021)

Single-cell RNA sequencing identifies G-protein coupled receptor 87 as a basal cell marker expressed in distal honeycomb cysts in idiopathic pulmonary fibrosis
por: Heinzelmann, Katharina, et al.
Publicado: (2022)

BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN)
por: Gaisl, Thomas, et al.
Publicado: (2021)

Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial
por: Milne, Stephen, et al.
Publicado: (2021)

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
por: Tadolini, Marina, et al.
Publicado: (2020)

Added value of chest computed tomography in suspected COVID-19: an analysis of 239 patients
por: Korevaar, Daniël A., et al.
Publicado: (2020)

Job strain and COPD exacerbations: an individual-participant meta-analysis
por: Heikkilä, Katriina, et al.
Publicado: (2014)

Supporting progress towards the post-2015 targets and regional tuberculosis elimination: a statement of intent from the third meeting of the Asian TB Experts Community
por: Mori, Toru, et al.
Publicado: (2015)

Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
por: Wells, Charles D., et al.
Publicado: (2015)

Numbers needed to treat to prevent tuberculosis
por: Matteelli, Alberto, et al.
Publicado: (2015)

Breathlessness, physical activity and sustainability of healthcare
por: Aitsi-Selmi, Amina, et al.
Publicado: (2015)

Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma
por: Ierodiakonou, Despo, et al.
Publicado: (2016)

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion
por: Sotgiu, Giovanni, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gvvm260iqj704b4cjgtjfog698